[{"Assets_0_Q2_USD":21725395.0,"CommonStockSharesOutstanding_0_Q2_shares":26252562.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-14347719.0,"NetIncomeLoss_2_Q2_USD":-13086475.0,"NetIncomeLoss_1_Q2_USD":-8280916.0,"StockholdersEquity_0_Q2_USD":7008899.0,"Ticker":"AXSM","CIK":"1579428","name":"AXSOME THERAPEUTICS, INC.","OfficialName":"Axsome Therapeutics Inc. Common Stock","form":"10-Q","period":"20180630","fy":"2018.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1574461367.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20180808"}]